Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Patient Derived Xenograft / PDX Models
... the year 2023, is expected to reach US$510.8 Million by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Pre-Clinical Drug Development Application, one of the segments analyzed in the report, is ... Read More
-
Genomics in Cancer Care
... reach US$62.1 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$25.0 ... Read More
-
Humanized Mouse and Rat Model
... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Cold Plasma
... at a CAGR of 14.7% over the analysis period 2023-2030. Polymer & Plastics End-Use, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the ... Read More
-
Biotech Business October 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
PEGylated Proteins
... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Peptide Synthesis
... at a CAGR of 4.3% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Human Liver Models
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$225.8 Million ... Read More
-
Neuroscience
... of 3.8% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$29.9 Billion by the end of the analysis period. ... Read More
-
Albumin
... of 3.7% over the analysis period 2023-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis ... Read More
-
Immune Checkpoint Inhibitors
... by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Lung Cancer, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$69.3 Billion by ... Read More
-
Cancer Immunotherapy
... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More
-
Healthcare Contract Management Software
... reach US$8.7 Billion by 2030, growing at a CAGR of 19.3% over the analysis period 2023-2030. Healthcare Contract Management Software, one of the segments analyzed in the report, is expected to record a 20.1% CAGR ... Read More
-
Beta Interferon
... at a CAGR of 3.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$943.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is ... Read More
-
Global Human Liver Models Market 2024-2028
... human liver models market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Synthetic Biology Service Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Synthetic Biology Service is forecast to a readjusted size of US$ 1529 million by 2030 with a CAGR of 3.3% during review period. The research report highlights the growth potential ... Read More
-
Global Synthetic Biology Platforms Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Synthetic Biology Platforms is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030
... & New Zealand Research Antibodies Market Growth & Trends The Australia & New Zealand research antibodies market size is expected to reach USD 77.6 million by 2030, registering a CAGR of 4.8% from 2024 to ... Read More
-
Life Science Analytics Software Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... global life science analytics software market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global life science analytics ... Read More
-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... market is expected to grow at a CAGR of around 11.2% during 2025-2034. This report on global autologous stem cell and non-stem cell based therapies market report provides holistic understanding of the market along with ... Read More
-
2024 Global: Albumins; Albuminates And Other Derivatives (Excluding Egg Albumin) Products-Manufacturing Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Biotech Research and Development - 2024 U.S. Market Research Report with Updated Analysis & Forecasts
... the industry in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, ... Read More
-
Biotech Business September 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Bone Marrow Transplant
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Myeloma Indication, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.8 Billion by ... Read More
Research Assistance
